Zobrazeno 1 - 10 of 16 pro vyhledávání: '"Juliette H R J Degens"'
3
The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer
Autor: Traverso, Haiyan Zeng, Fariba Tohidinezhad, Dirk K. M. De Ruysscher, Yves C. P. Willems, Juliette H. R. J. Degens, Vivian E. M. van Kampen-van den Boogaart, Cordula Pitz, Francesco Cortiula, Lloyd Brandts, Lizza E. L. Hendriks, Alberto
Publikováno v: Cancers; Volume 15; Issue 11; Pages: 3010
Purpose: To identify clinical risk factors, including gross tumor volume (GTV) and radiomics features, for developing brain metastases (BM) in patients with radically treated stage III non-small cell lung cancer (NSCLC). Methods: Clinical data and pl
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=multidiscipl::4fa1c19ae66f003867b0c61cb8ec2b20
Zobrazit plný text záznamu
5
Identification of microRNAs in skeletal muscle associated with lung cancer cachexia
Autor: Wouter R. P. H. van de Worp, Susan L. Coort, Marco C. J. M. Kelders, Jan Theys, Annemie M. W. J. Schols, Juliette H R J Degens, Ardy van Helvoort, Henry C. Woodruff, Annick Harel‐Bellan, Celine M. Op den Kamp, Ramon C. J. Langen, Gueorqui Kratassiouk, Anne-Marie C. Dingemans
Publikováno v: Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, 2019, ⟨10.1002/jcsm.12512⟩
Journal of cachexia, sarcopenia and muscle, 11(2), 452-463. Wiley
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 2, Pp 452-463 (2020)
Background Cachexia, highly prevalent in patients with non‐small cell lung cancer (NSCLC), impairs quality of life and is associated with reduced tolerance and responsiveness to cancer therapy and decreased survival. MicroRNAs (miRNAs) are small no
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96761848e88c9143669115e10f7124b5
https://doi.org/10.1002/jcsm.12512
Zobrazit plný text záznamu
6
The prognostic value of weight and body composition changes in patients with non-small-cell lung cancer treated with nivolumab
Autor: Hester A. Gietema, Annemie M. W. J. Schols, Juliette H R J Degens, Anne-Marie C. Dingemans, Anna C.H. Willemsen, Joachim G.J.V. Aerts, Lizza E.L. Hendriks, Daan P. Hurkmans
Publikováno v: Journal of cachexia, sarcopenia and muscle, 12(3), 657-664. Wiley
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 3, Pp 657-664 (2021)
Journal of Cachexia, Sarcopenia and Muscle, 12(3), 657-664. Wiley-Blackwell
Journal of Cachexia, Sarcopenia and Muscle
Background It is not well known to what extent effectiveness of treatment with immune checkpoint inhibitors in stage IV non-small-cell lung cancer (NSCLC) is influenced by weight loss and changes in body composition. Therefore, the goal of this study
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa2d04e6df06626f53acf5764dac64d6
https://cris.maastrichtuniversity.nl/en/publications/caa83957-86e6-444b-8a06-e9d54b46a608
Zobrazit plný text záznamu
7
Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study
Autor: Anne-Marie C. Dingemans, Ruud Houben, Lizza E.L. Hendriks, Bastiaan Kietselaer, Juliette H R J Degens, Gerben Bootsma, Dirk De Ruysscher, Annemie M. W. J. Schols, Ellen Huijbers
Publikováno v: BMJ Open, 10(9):036492. BMJ Publishing Group
BMJ Open, 10(9):e036492. BMJ Publishing Group
BMJ Open, Vol 10, Iss 9 (2020)
BMJ Open
ObjectivesDyspnoea is one of the symptoms frequently encountered after treatment with chemoradiotherapy (CRT) in stage III non-small cell lung cancer (NSCLC). Long-term data on mild to moderately severe cardiac events as underlying cause of dyspnoea
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2f3e7749909281cd0d6cddcc4f00c2
https://cris.maastrichtuniversity.nl/en/publications/6669f08e-3943-41cd-ac9c-061e2c8c466f
Zobrazit plný text záznamu
8
Development and Validation of a Patient-reported Score to Screen for Mucosal Inflammation in Inflammatory Bowel Disease
Autor: Igor Romanko, Ad A.M. Masclee, Alexander Bodelier, Marin J de Jong, Marie J. Pierik, Daisy Jonkers, Astrid van Tubergen, Tineke Markus, Juliette H R J Degens, Tim van den Heuvel, Milan Lukas, Mariëlle Romberg-Camps, Bjorn Winkens, Danielle Roosen, Wim Hameeteman
Publikováno v: Journal of Crohn's & Colitis, 13(5), 555-563. Oxford University Press
Background and Aims: Patient-reported outcome measures [PROMs] assessing inflammatory bowel disease [IBD] activity are of interest for monitoring in clinical practice, telemedicine systems, or trials. Different PROMs for follow-up of disease activity
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b06d62e3618b2ab76333bddcd699aa
https://doi.org/10.1093/ecco-jcc/jjy196
Zobrazit plný text záznamu
9
The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer
Autor: Karin J. C. Sanders, E.E.C. De Jong, Egbert F. Smit, Juliette H R J Degens, Anne-Marie C. Dingemans, Joachim G.J.V. Aerts, Annemie M. W. J. Schols, Harry J.M. Groen
Publikováno v: Lung Cancer, 133, 130-135. ELSEVIER IRELAND LTD
Lung Cancer, 133, 130-135. Elsevier Ireland Ltd
Objectives: To evaluate the relationship between early changes in muscle and adipose tissue during chemotherapy and overall survival (OS) in stage IV non-small cell lung cancer (NSCLC).Materials and methods: In this post-hoc analysis of the first lin
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::032b0ccbfba722de14cd367da397eed4
https://research.rug.nl/en/publications/2c5e28ce-8a9b-45ba-a112-042cedc7902f
Zobrazit plný text záznamu
10
Can radiomics help to predict skeletal muscle response to chemotherapy in stage IV non-small cell lung cancer?
Autor: E.E.C. De Jong, Timo M. Deist, Juliette H R J Degens, J. van Timmeren, Anne-Marie C. Dingemans, Karin J. C. Sanders, W. Van Elmpt, Ralph T.H. Leijenaar, Annemie M. W. J. Schols, Philippe Lambin, Arthur Jochems
Publikováno v: European Journal of Cancer, 120, 107-113. ELSEVIER SCI LTD
Background: Muscle depletion negatively impacts treatment efficacy and survival rates in cancer. Prevention and timely treatment of muscle loss require prediction of patients at risk. We aimed to investigate the potential of skeletal muscle radiomic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72590a98c46be6f82542f6dc63b0af50
https://pubmed.ncbi.nlm.nih.gov/31514107
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje